Erythropoietin: A new job for an old friend;Erythropoietin - En ny terapi ved cerebral iskæmi?

Ugeskrift for Laeger

Volumn 165, Issue 24, 2003, Pages 2477-2481

  Kalialis, Louise Vennegaard ^b   Olsen, Niels Vidiendal ^a  

^a Rigshospitalet   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT HORMONE; STAT5 PROTEIN; NEUROPROTECTIVE AGENT;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ASTROCYTE; AUTOREGULATION; BRAIN BLOOD FLOW; BRAIN CAPILLARY; BRAIN ISCHEMIA; DRUG MECHANISM; DRUG SAFETY; ENDOTHELIUM CELL; ERYTHROPOIESIS; GLIA CELL; HUMAN; HYPOXIA; IN VIVO STUDY; NERVE CELL; NERVE INJURY; NEUROPROTECTION; NEUROTROPISM; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIGNAL TRANSDUCTION; STROKE; SUBARACHNOID HEMORRHAGE; SYSTEMIC THERAPY; TREATMENT INDICATION; UPREGULATION; ANIMAL; CEREBROVASCULAR ACCIDENT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM;

ANIMALS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; ERYTHROPOIETIN, RECOMBINANT; HUMANS; INJECTIONS, INTRAVENTRICULAR; NEURONS; NEUROPROTECTIVE AGENTS; RECEPTORS, ERYTHROPOIETIN;

EID: 0042205823     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Tan CC, Eckardt KU, Firth JD et al. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol 1992;263:F474-81.
2. Digicaylioglu M, Bichet S, Marti HH et al. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci U S A 1995;92:3717-20.
3. Marti HH, Wenger RH, Rivas LA et al. Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 1996;8:666-76.
4. Juul SE, Anderson DK, Li Y et al. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res 1998;43:40-49.
5. Bernaudin M, Marti HH, Roussel S et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 1999;19:643-51.
6. Bernaudin M, Bellail A, Marti HH et al. Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia 2000;30:271-8.
7. Masuda S, Okano M, Yamagishi K et al. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 1994;269:19488-93.
8. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999;79:1431-568.
9. Masuda S, Nagao M, Takahata K et al. Functional erythropoietin receptor of the cells with neural characteristics. J Biol Chem 1993;268:11208-16.
10. Morishita E, Masuda S, Nagao M et al. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 1997;76:105-6.
11. Brines ML, Ghezzi P, Keenan S et al Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000;97:10526-31.
12. Yamaji R, Okada T, Moriya M et al. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem 1996;239:494-500.
13. Kisseleva T, Bhattacharya S, Braunstein J et al. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 2002;285: 1-24.
14. Chin K, Yu X, Beleslin-Cokic B et al. Production and processing of erythropoietin receptor transcripts in brain. Brain Res Mol Brain Res 2000;81: 29-42.
15. Marti HH, Gassmann M, Wenger RH et al. Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain. Kidney Int 1997;51:416-8.
16. Siren AL, Knerlich F, Poser W et al. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol (Berl) 2001; 101:271-6.
17. Sadamoto Y, Igase K, Sakanaka M et al. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem Biophys Res Commun 1998;253:26-32.
18. Sakanaka M, Wen TC, Matsuda S et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 1998;95: 4635-40.
19. Siren AL, Fratelli M, Brines M et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 2001;98:4044-49.
20. Calapai G, Marciano MC, Corica F et al. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol 2000;401:349-56.
21. Alafaci C, Salpietro F, Grasso G et al. Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage. Eur J Pharmacol 2000;406:219-25.
22. Buemi M, Grasso G, Corica F et al. In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhage. Eur J Pharmacol 2000;392:31-4.
23. Springborg JB, Ma X, Rochat P et al. A single subcutaneous bolus of recombinant erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid hemorrhage in rats. Br J Pharmacol 2002;135:823-9.
24. Celik M. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA 2002;99:2258-63.
25. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001;412:641-7.
26. Chong ZZ, Kang JQ, Maiese K. Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J Cereb Blood Flow Metab 2002;22:503-14.
27. Chattopadhyay A, Choudhury TD, Bandyopadhyay D et al. Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem Pharmacol 2000;59:419-25.
28. Squadrito F, Altavilla D, Squadrito G et al. Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock. Br J Pharmacol 1999;127:482-8.
29. Kusano E, Akimoto T, Inoue M et al. Human recombinant erythropoietin inhibits interleukin-1beta-stimulated nitric oxide and cyclic guanosine monophosphate production in cultured rat vascular smooth-muscle cells. Nephrol Dial Transplant 1999;14:597-603.
30. Akimoto T, Kusano E, Muto S et al. The effect of erythropoietin on interleukin-1beta mediated increase in nitric oxide synthesis in vascular smooth muscle cells. J Hypertens 1999;17:1249-56.
31. Faraci FM, Heistad DD. Regulation of the cerebral circulation; role of endothelium and potassium channels. Physiol Rev 1998;78:53-97.
32. Ribatti D, Presta M, Vacca A et al. Human erythropoietin induces a proangiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 1999;93:2627-36.
33. Koshimura K, Murakami Y, Sohmiya M et al. Effects of erythropoietin on neuronal activity. J Neurochem 1999;72:2565-72.
34. Konishi Y, Chui DH, Hirose H et al. Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res 1993;609:29-35.
35. Campana WM, Misasi R, O'Brien JS. Identification of a neurotrophic sequence in erythropoietin. Int J Mol Med 1998;1:235-41.
36. Cheung WK, Goon BL, Guilfoyle MC et al. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects. Clin Pharmacol Ther 1998;64:412-23.
37. Luft FC. Erythropoietin and arterial hypertension. Clin Nephrol 2000;53:S61-4.